Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Allethrin caused harmful effects and organ damage in rats, worsening with higher doses and longer exposure.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Baricitinib was effective in treating both early and late onset alopecia areata.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Tofacitinib treatment is used for teenagers with alopecia areata.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Men with male pattern baldness have higher levels of A-FABP, which might help in early detection.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Higher FABP4 levels may indicate more severe alopecia areata.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Baricitinib works better than methotrexate for severe alopecia areata.

ALDOA levels drop in hair cells during hair loss.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

CTP-543 is generally safe for treating alopecia areata.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.